Herbst Kinsky advised Marinomed Biotech, while Schoenherr advised Nice & Green on the deal.Marinomed Biotech AG (VSE:MARI), an Austrian science-based biotech company with globally marketed therapeutics…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
